Navigation Links
HISTOGRIP from Invitrogen
Mouse Anti-IFN-alpha2 Monoclonal Antibody, Fluorescein isothiocyanate (FITC) Conjugated, Clone 225.C from eBioscience
Mouse Anti-alpha Sodium Potassium ATPase Monoclonal Antibody, Unconjugated, Clone M7-PB-E9 from Abcam
Rabbit Anti-Human SP2 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Rabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam
Biology Products:
(Date:11/4/2009)...Norman has received more than $10 million in resea...he federal stimulus program, bringing thetotal amo... to $23 million. Thirty-three projects achieved s...gy to weather. , "The university has thoughtfull...asof scholarly excellence to federal agency priori...
(Date:11/4/2009)... 20 DigitalPersona, Inc., a leader...ons, today announced that WAND Corporation, a lead...uick-service restaurants, has integrated DigitalPe...c POS solutions. WAND,s quick-service customers ca...accountability and deter unauthorized manager over...
(Date:11/4/2009)... GenVault Corporation, the leader i...omic discovery, medicine and identification, today...esident and CEO, will be presenting at the BIOCOM ...nd 27th in La Jolla, CA. ,, During the presenta...ompany together with recent customer, technical an...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Blue Cross and Blue Shield of Texas Collaborates With Five Blue Plans to Increase Transparency Expand Access to Health Care Cost Information 53234 1Blue Cross and Blue Shield of Texas Collaborates With Five Blue Plans to Increase Transparency Expand Access to Health Care Cost Information 53234 2Insurance Department Releases Report on Executive Compensation at States Largest Blues Plans 53231 1Insurance Department Releases Report on Executive Compensation at States Largest Blues Plans 53231 2MDS Nordion Submits Expression of Interest Proposal to Government of Canada on Medical Isotope and Generator Production 53229 1MDS Nordion Submits Expression of Interest Proposal to Government of Canada on Medical Isotope and Generator Production 53229 2MDS Nordion Submits Expression of Interest Proposal to Government of Canada on Medical Isotope and Generator Production 53229 3
...eat attention was attracted by the discovery that ...proteins using statistical methods. In an article ... of Science (PNAS) Uppsala researchers are now pre... theory. , Proteins govern nearly all chemical pr...y of proteins is their ability to transfer signals...
...larly been introducing exotic species into natural...ional necessities or meet less indispensable purpo...ver, the particular environments are not always ad...attempts, such as that of wild rabbit into Austral...ater courses, led to an awareness that these diffe...
...rating in a NASA-funded project, using a CSIRO-des...easuring forest carbon stores on a large scale., F...re and are therefore critical in controlling the g...arbon stored in forests over a large scale is diff...gned ECHIDNA instrument, together with airborne se...
Other Biology News:Statistics are insufficient for study of proteins' signal system 2Conservation of freshwater fish biodiversity: a challenge for the countries of the South 2Conservation of freshwater fish biodiversity: a challenge for the countries of the South 3
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personali... to take place on February 22-24, 2010 in Philadel...ence we will highlight key issues in forming partn...r experiences. , Minneapo... Arrowhead’s 2010 Personalized Medicine Par...
(Date:11/5/2009)... Nov. 5 DSM Pharmaceutical Product... alliance with Galenix, Saint Jean D,Illac, France... manufacturing partner for Galenix commercial prod... collaborate on business development opportunities...based on the strength of Galenix in drug product d...
(Date:11/5/2009)... 5 Transgenomic, Inc. (O... results for the quarter ended September 30, 2009....the tables that follow. ,, Third Quarter 2009 ... or $0.01 per share for the third quarter of 2009 ... share for the third quarter of 2008. ,, Net s...
(Date:11/5/2009)...vember 5, 2009 Senomyx, ...proprietary taste receptor-based technologies to d...erage, and ingredient supply industries, today pro...sults for the third quarter ended September 30, 20...ter of 2009, compared to $4.0 million for the thir...
Breaking Biology Technology:Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14